'Risperdal' (Risperidone) an antipsychotic drug has been for the first time given the green signal to be implemented for symptomatic treatment of emotional disturbances in children and teenagers suffering from Autism, by The U.S. Food and Drug Administration.
An antipsychotic drug generally employed in the treatment of adults, Risperidone will thus become the first one in its league to be used in treating children affected with Autism.
Risperdal was first approved and implemented in the short-term treatment of Schizophrenia in adults way back in 1993. In 2003 it was cleared for short term treatment of mania and mixed outbreaks of extreme mood swings as well.. Now the FDA has cleared this drug to be safely implemented in the treatment of behavior disorders in autistic children that suggest irritability, which includes temper tantrums, attempted self-mutilation, and aggression.
Steven Galson, M.D., director of FDA's Center for Drug Evaluation and Research was hopeful that this drug would be of great benefit for many autistic children. He also emphasized that the agency he represents firmly believes in encouraging development of apt drugs that can be employed in treating children, which were hitherto used among adults.